Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Primary Myelofibrosis 1Polycythemia Vera 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myeloid 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 28Whole-Body Irradiation 20fludarabine phosphate 19Mycophenolic Acid 15Methotrexate 14fludarabine 13Cytarabine 13Busulfan 13Peripheral Blood Stem Cell Transplantation 11venetoclax 10Cord Blood Stem Cell Transplantation 10Tacrolimus 9Cyclosporine 9Vincristine 8Thiotepa 7Methylprednisolone 7Mercaptopurine 7Melphalan 7Filgrastim 7Dexamethasone 7Azacitidine 7Asparaginase 7Antilymphocyte Serum 7Hydrocortisone 6Daunorubicin 6merphos 5Specimen Handling 5Radiotherapy 5Granulocyte Colony-Stimulating Factor 5Cyclosporins 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Biphenotypic, Acute × methanesulfonic acid × Clear all
NCT03683433 2026-03-05

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

M.D. Anderson Cancer Center

Phase 2 Recruiting
50 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡